NCT04869800View on ClinicalTrials.gov

Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

June 7, 2021

Study Completion Date

June 15, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CKD-398

Test Drug

DRUG

CKD-501, D745

Reference Drug

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY